LGVN (longeveron.com) Rasio nilai perusahaan marang pendapatan

The enterprise value-to-revenue multiple confirms the high reputation of Longeveron Inc. (LGVN) in regenerative medicine due to the development of safe Alzheimer's treatments, where -598.29 represents the current metric level. Innovations in cellular tissue restoration for longevity combine with investor confidence in the updated management following the publication of successful clinical results.
LGVN (Longeveron Inc.): rincian analitis lan laporan miturut indikator

Longeveron Inc. utilizes its own drug production laboratories to minimize external costs, which directly impacts the dynamics of the enterprise value-to-annual revenue multiple. This indicator compares market capitalization, adjusted for net debt, against sales volume, allowing investors to assess the fairness of the current business valuation; however, abnormally low values may signal fundamental risks or a "value trap."